Boundless Bio to Participate in the Leerink Global Healthcare Conference
Boundless Bio to Participate in the Leerink Global Healthcare Conference is drawing significant interest across the industry.
SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in a fireside chat at the Leerink Global Healthcare Conference.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Google Maps will finally be usable in South Korea
- How a U.S. strike on Iran could affect American drivers and borrowers
- Why 60-year-olds in China are queuing up to learn OpenClaw
- In Paris fashion, skin is in and celebrities rule the runways
Source: Original →